Evaluation of two homogeneous methods for measuring high-density lipoprotein cholesterol

被引:0
|
作者
Huang, YC
Kao, JT
Tsai, KS
机构
[1] NATL TAIWAN UNIV HOSP,COLL MED,DEPT LAB MED,TAIPEI 10016,TAIWAN
[2] NATL TAIWAN UNIV,COLL MED,SCH MED TECHNOL,TAIPEI 10016,TAIWAN
[3] MUNICIPAL HO PIN HOSP,DEPT LAB MED,TAIPEI,TAIWAN
关键词
methods comparison; triglycerides; atherosclerosis;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We evaluated the performance of two homogeneous assays for quantifying HDL cholesterol (HDL-C) and compared them with the phosphotungstic acid (PTA)/MgCl2 assay. Both homogeneous HDL-C assays were precise, having a within-run CV of <1.20% and a between-run CV of <4.07%. The HDL-C values (y) measured by the two homogeneous methods correlated well with those by the PTA/MgCl2 method (x): y = 1.00x + 64.98 mg/L, r = 0.987, S-y/x = 27.99 mg/L (n = 152) for the polyethylene glycol-modified enzymes/alpha-cyclodextrin sulfate (PEGME) assay (Kyowa), and y = 0.84x + 106.51 mg/L, r = 0.984, S-y/x = 26.10 mg/L (n = 152) for the polyanion-polymer/detergent (PPD) assay (Daiichi). The specificity of the PEGME method seemed better than that of the PPD method, as the PPD method was markedly interfered with by supplemental LDL-C. Addition of 20 g/L triglycerides produced a negative error of similar to 18% in both homogeneous assays. Bilirubin and hemoglobin had little influence on the PEGME method; hemoglobin had little effect on the PPD method. Bilirubin, however, markedly decreased the readings by the PPD method. We found the PEGME assay superior to the PPD assay for routine HDL-C testing, because the PPD assay is relatively inaccurate and not specific.
引用
收藏
页码:1048 / 1055
页数:8
相关论文
共 50 条
  • [41] A two-step homogeneous assay for apolipoprotein E-containing high-density lipoprotein-cholesterol
    Takahashi, Yuji
    Ito, Yasuki
    Sakurai, Toshihiro
    Wada, Norio
    Nagasaka, Atsushi
    Fujikawa, Masato
    Chiba, Hitoshi
    Hui, Shu-Ping
    ANNALS OF CLINICAL BIOCHEMISTRY, 2019, 56 (01) : 123 - 132
  • [42] Is Non-High-Density Lipoprotein Cholesterol Evaluation Perfect? From the High-Density Lipoprotein Function Viewpoint
    Otsuka, Toshiaki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (09) : 1271 - 1272
  • [43] Serum amyloid A does not affect high-density lipoprotein cholesterol measurement by a homogeneous assay
    Sato, Megumi
    Ohkawa, Ryunosuke
    Low, Hann
    Nishimori, Madoka
    Okubo, Shigeo
    Yoshimoto, Akira
    Yano, Kouji
    Kameda, Takahiro
    Yatomi, Yutaka
    Tozuka, Minoru
    CLINICAL BIOCHEMISTRY, 2019, 63 : 97 - 101
  • [44] Aggressive treatment of high-density lipoprotein cholesterol
    Nicholls, SJ
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) : 1025 - 1025
  • [45] INCORPORATION OF CHOLESTEROL INTO HIGH-DENSITY LIPOPROTEIN RECOMBINANTS
    TALL, AR
    LANGE, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1978, 80 (01) : 206 - 212
  • [46] SENSITIVE HIGH-DENSITY LIPOPROTEIN CHOLESTEROL ASSAY
    ARTISS, JD
    MCGOWAN, MW
    ZAK, B
    MICROCHEMICAL JOURNAL, 1981, 26 (02) : 198 - 209
  • [47] EFFECTS OF DIET ON HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
    FLANAGAN, M
    LITTLE, C
    MILLIKEN, J
    WRIGHT, E
    MCGILL, AR
    WEIR, DG
    OMOORE, RR
    JOURNAL OF HUMAN NUTRITION, 1980, 34 (01): : 43 - 45
  • [48] Effects of Diet on High-Density Lipoprotein Cholesterol
    Siri-Tarino, Patty W.
    CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (06) : 453 - 460
  • [49] The role of high-density lipoprotein cholesterol in atherothrombosis
    Choi, Brian G.
    Vilahur, Gemma
    Viles-Gonzalez, Juan F.
    Badimon, Juan J.
    MOUNT SINAI JOURNAL OF MEDICINE, 2006, 73 (04): : 690 - 701
  • [50] HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL IN DIABETICS
    STANTON, K
    MASSEREI, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1979, 9 (01): : 109 - 110